Bio Vitos Pharma AB (publ) HEMC.ST Stock
Bio Vitos Pharma AB (publ) Price Chart
Bio Vitos Pharma AB (publ) HEMC.ST Financial and Trading Overview
Bio Vitos Pharma AB (publ) stock price | 0.23 SEK |
Previous Close | 0.31 SEK |
Open | 0.29 SEK |
Bid | 0.31 SEK x 0 |
Ask | 0.33 SEK x 0 |
Day's Range | 0.29 - 0.31 SEK |
52 Week Range | 0.16 - 1.25 SEK |
Volume | 5.12K SEK |
Avg. Volume | 192.93K SEK |
Market Cap | 10.69M SEK |
Beta (5Y Monthly) | 1.067432 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 SEK |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HEMC.ST Valuation Measures
Enterprise Value | 8.38M SEK |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.5760965 |
Price/Book (mrq) | 0.49053627 |
Enterprise Value/Revenue | 2.021 |
Enterprise Value/EBITDA | -0.627 |
Trading Information
Bio Vitos Pharma AB (publ) Stock Price History
Beta (5Y Monthly) | 1.067432 |
52-Week Change | -37.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.25 SEK |
52 Week Low | 0.16 SEK |
50-Day Moving Average | 0.34 SEK |
200-Day Moving Average | 0.36 SEK |
HEMC.ST Share Statistics
Avg. Volume (3 month) | 192.93K SEK |
Avg. Daily Volume (10-Days) | 13.84K SEK |
Shares Outstanding | 34.37M |
Float | 23.62M |
Short Ratio | N/A |
% Held by Insiders | 37.77% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -341.66% |
Gross Margin | 78.72% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -32.20% |
Return on Equity (ttm) | -55.015% |
Income Statement
Revenue (ttm) | 4.15M SEK |
Revenue Per Share (ttm) | 0.14 SEK |
Quarterly Revenue Growth (yoy) | -53.00000000000000000000000000000000% |
Gross Profit (ttm) | 3.64M SEK |
EBITDA | -13367615 SEK |
Net Income Avi to Common (ttm) | -14139877 SEK |
Diluted EPS (ttm) | -0.31 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.03M SEK |
Total Cash Per Share (mrq) | 0.06 SEK |
Total Debt (mrq) | 0 SEK |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 2.82 |
Book Value Per Share (mrq) | 0.634 |
Cash Flow Statement
Operating Cash Flow (ttm) | -7075909 SEK |
Levered Free Cash Flow (ttm) | -4690900 SEK |
Profile of Bio Vitos Pharma AB (publ)
Country | Sweden |
State | N/A |
City | Solna |
Address | Nanna Svartz väg 4 |
ZIP | 171 65 |
Phone | 46 7 61 08 81 91 |
Website | https://www.hemcheck.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 3 |
Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden and internationally. The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples. It serves emergency departments in the European Union and the United States. The company was incorporated in 2010 and is based in Solna, Sweden.
Q&A For Bio Vitos Pharma AB (publ) Stock
What is a current HEMC.ST stock price?
Bio Vitos Pharma AB (publ) HEMC.ST stock price today per share is 0.23 SEK.
How to purchase Bio Vitos Pharma AB (publ) stock?
You can buy HEMC.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bio Vitos Pharma AB (publ)?
The stock symbol or ticker of Bio Vitos Pharma AB (publ) is HEMC.ST.
Which industry does the Bio Vitos Pharma AB (publ) company belong to?
The Bio Vitos Pharma AB (publ) industry is Medical Devices.
How many shares does Bio Vitos Pharma AB (publ) have in circulation?
The max supply of Bio Vitos Pharma AB (publ) shares is 38.02M.
What is Bio Vitos Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Bio Vitos Pharma AB (publ) PE Ratio is 0.00000000 now.
What was Bio Vitos Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Bio Vitos Pharma AB (publ) EPS is 0 SEK over the trailing 12 months.
Which sector does the Bio Vitos Pharma AB (publ) company belong to?
The Bio Vitos Pharma AB (publ) sector is Healthcare.
Bio Vitos Pharma AB (publ) HEMC.ST included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}